European Urology Oncology

Slides:

Advertisements

Similar presentations

Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for.

Advertisements

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Surgical Management of Renal Cell Carcinoma with Tumor Thrombus in the Renal and Inferior Vena Cava: The University of Miami Experience in Using Liver.

1906 PREOPERATIVE PULMONARY EMBOLISM DOES NOT PREDICT POOR POSTSURGICAL OUTCOMES IN RCC PATIENTS WITH VENOUS THROMBUS E. Jason Abel, Christopher G. Wood,

Surgical Management of Renal Cell Carcinoma with Tumor Thrombus in the Renal and Inferior Vena Cava: The University of Miami Experience in Using Liver.

European Urology Oncology

Volume 49, Issue 2, Pages (February 2006)

Volume 61, Issue 5, Pages (May 2012)

Surgical treatment of renal cell carcinoma with right atrial thrombus: Early experience and description of a simplified technique T. Modine, S. Haulon,

Renal cell carcinoma with extension of tumor thrombus into the vena cava: Surgical strategy and prognosis Yoshihiko Tsuji, MDa, Akinobu Goto, MDb, Isao.

Volume 59, Issue 4, Pages (April 2011)

Volume 53, Issue 4, Pages (April 2008)

Volume 51, Issue 3, Pages (March 2007)

European Urology Oncology

European Urology Oncology

Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes Solomon L. Woldu, Joseph A. Moore,

Ziya Kirkali, Hein Van Poppel European Urology

Volume 68, Issue 1, Pages (July 2015)

European Urology Oncology

Figure 2 Representative images from a right radical

Volume 66, Issue 3, Pages (September 2014)

Volume 69, Issue 6, Pages (June 2016)

Volume 67, Issue 4, Pages (April 2015)

Volume 63, Issue 1, Pages (January 2013)

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

European Urology Oncology

Nomograms for Bladder Cancer

Volume 52, Issue 5, Pages (November 2007)

Volume 47, Issue 3, Pages (March 2005)

Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis Mohamad B. Sonbol, Belal Firwana, Talal.

Volume 58, Issue 4, Pages (October 2010)

European Urology Oncology

Novel Approach to Recurrent Cavoatrial Renal Cell Carcinoma

European Urology Oncology

European Urology Oncology

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 61, Issue 6, Pages (June 2012)

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,

Volume 64, Issue 4, Pages (October 2013)

Volume 74, Issue 3, Pages (September 2018)

Volume 66, Issue 6, Pages (December 2014)

Volume 54, Issue 4, Pages (October 2008)

Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery

Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL,

Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Volume 50, Issue 2, Pages (August 2006)

Renal Carcinoma With Supradiaphragmatic Tumor Thrombus: Avoiding Sternotomy and Cardiopulmonary Bypass Gaetano Ciancio, MD, Samir P. Shirodkar, MD, Mark.

Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus Emanuele Belgrano, Carlo Trombetta, Salvatore Siracusano, Giorgio Carmignani,

European Urology Oncology

Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma Sung Shin, MD, Youngjin Han,

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy Matthew Mossanen, Kenneth.

Gary W. Barone, MD, Mark B. Kahn, MD, James M. Cook, MD, Timothy C

European Urology Oncology

Sergio Bracarda European Urology Supplements

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

European Urology Oncology

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Joaquim Bellmunt European Urology Supplements

European Urology Oncology

Palliative iliac vein-to-right atrium bypass in a patient with a prior vena cava ligation for invasive renal cell carcinoma Joshua C. Grimm, MD, Robert.

Dual Inferior Vena Cava: Two Inferior Vena Cava Filters

Jan Roigas European Urology Supplements

Renal cell carcinoma with inferior vena caval involvement

European Urology Oncology

European Urology Oncology

Rashed Ghandour, Nirmish Singla, Yair Lotan Trends in Cancer

Maximilian Burger, Ashish M. Kamat, David McConkey

Contemporary techniques and safety of cardiovascular procedures in the surgical management of renal cell carcinoma with tumor thrombus Jordon G. Lubahn,

Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma Guillermo de Velasco, Axel Bex, Laurence Albiges, Thomas Powles, Brian.

Presentation transcript:

European Urology Oncology Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy Yuval Freifeld, Solomon L. Woldu, Nirmish Singla, Timothy Clinton, Aditya Bagrodia, Ryan Hutchinson, Yair Lotan, Vitaly Margulis European Urology Oncology DOI: 10.1016/j.euo.2018.10.005 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Hospital case volume. European Urology Oncology DOI: (10.1016/j.euo.2018.10.005) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 pT3b (A) and pT3c (B) 30-d and 90-d mortality rates stratified according to hospital case volume. European Urology Oncology DOI: (10.1016/j.euo.2018.10.005) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 3 Overall survival (OS) for the whole cohort. European Urology Oncology DOI: (10.1016/j.euo.2018.10.005) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 4 Overall survival (OS) stratified according to hospital case volume. (A) Subdiaphragmatic inferior vena cava tumor thrombus (IVC-TT) in pT3b, N0–1, M0–1 renal cell carcinoma. (B) Supradiaphragmatic IVC-TT in pT3c, N0–1, M0–1 renal cell carcinoma. (C) Nonmetastatic pT3b–3c, N0–1, M0–1 renal cell carcinoma. Metastatic pT3b–3c, N0–1, M0–1 renal cell carcinoma. European Urology Oncology DOI: (10.1016/j.euo.2018.10.005) Copyright © 2018 European Association of Urology Terms and Conditions

European Urology Oncology DOI: (10.1016/j.euo.2018.10.005) Copyright © 2018 European Association of Urology Terms and Conditions